Biotech · Private company
Cybrexa Therapeutics
Track this companyFree. Adds Cybrexa Therapeutics to your Dealase workspace and tells you when its record changes.
Clinical trials20 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- CBX-12Phase 2 · Platinum-resistant Ovarian CancerClinicalTrials.gov · fetched Nov 12, 2026
- CBX-12Phase 2 · Solid Tumor, AdultClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study of CBX 12 in Subjects With Platinum Resistant or Refractory Ovarian CancerPHASE2 · TERMINATED · started Sep 25, 2024ClinicalTrials.gov NCT06315491 · fetched Nov 12, 2026
- Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid TumorsPHASE1_PHASE2 · COMPLETED · started May 3, 2021ClinicalTrials.gov NCT04902872 · fetched Nov 12, 2026